These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16184040)

  • 1. Is HIV-1 evolving to a less virulent (pathogenic) virus?
    Quiñones-Mateu ME
    AIDS; 2005 Oct; 19(15):1689-90. PubMed ID: 16184040
    [No Abstract]   [Full Text] [Related]  

  • 2. Is HIV-1 evolving to a less virulent form in humans?
    Ariën KK; Vanham G; Arts EJ
    Nat Rev Microbiol; 2007 Feb; 5(2):141-51. PubMed ID: 17203103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective.
    Fraser C; Lythgoe K; Leventhal GE; Shirreff G; Hollingsworth TD; Alizon S; Bonhoeffer S
    Science; 2014 Mar; 343(6177):1243727. PubMed ID: 24653038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological phenotypes of HIV-1 in pathogenesis and transmission.
    Fenyö EM; Fiore J; Karlsson A; Albert J; Scarlatti G
    Antibiot Chemother (1971); 1994; 46():18-24. PubMed ID: 7826036
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa.
    Aralaguppe SG; Winner D; Singh K; Sarafianos SG; Quiñones-Mateu ME; Sönnerborg A; Neogi U
    J Med Virol; 2017 Jan; 89(1):106-111. PubMed ID: 27328744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS vaccine trials in chimpanzees.
    Prince AM; Andrus L
    Science; 1998 Dec; 282(5397):2195-6. PubMed ID: 9890826
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evolution of HIV virus].
    Salminen M; Leinikki P
    Duodecim; 1996; 112(2):130-4. PubMed ID: 10590619
    [No Abstract]   [Full Text] [Related]  

  • 8. Replication rate and evolution in the human immunodeficiency virus.
    Kelly JK
    J Theor Biol; 1996 Jun; 180(4):359-64. PubMed ID: 8776467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV auxiliary proteins: an interface between the virus and the host.
    Janvier K; Petit C; Le Rouzic E; Schwartz O; Benichou S
    AIDS; 2000; 14 Suppl 3():S21-30. PubMed ID: 11086846
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-1 drug resistance: where do polymorphisms fit in?
    Theys K; Abecasis AB; Vandamme AM
    Future Microbiol; 2013 Mar; 8(3):303-6. PubMed ID: 23464368
    [No Abstract]   [Full Text] [Related]  

  • 11. The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control.
    Zaunders J; Dyer WB; Churchill M
    Curr Opin HIV AIDS; 2011 May; 6(3):151-6. PubMed ID: 21378562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 pathogenesis.
    Stevenson M
    Nat Med; 2003 Jul; 9(7):853-60. PubMed ID: 12835705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New perspectives on HIV pathogenesis. Viral replication is continuous throughout the course of disease.
    J Assoc Nurses AIDS Care; 1995; 6(4):26-7. PubMed ID: 7495989
    [No Abstract]   [Full Text] [Related]  

  • 14. Does residual virus replication during successful HAART lead to HIV-1 genetic evolution?
    Aquaro S; Svicher V; Perno CF
    J HIV Ther; 2006 Dec; 11(4):84-8. PubMed ID: 17578212
    [No Abstract]   [Full Text] [Related]  

  • 15. Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort.
    Gali Y; Berkhout B; Vanham G; Bakker M; Back NK; Ariën KK
    Virology; 2007 Jul; 364(1):140-6. PubMed ID: 17395236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of HIV replication.
    Siliciano JD; Siliciano RF
    Curr Opin HIV AIDS; 2010 Nov; 5(6):491-7. PubMed ID: 20978392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1st International Workshop on HIV Persistence during Therapy. St. Martin, December 10-12, 2003.
    Tossing G
    Eur J Med Res; 2004 Feb; 9(2):83-6. PubMed ID: 15090294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus.
    Duus KM; Miller ED; Smith JA; Kovalev GI; Su L
    J Virol; 2001 Apr; 75(8):3916-24. PubMed ID: 11264380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of multiple infection of cells on the evolutionary dynamics of HIV in vivo: implications for host adaptation mechanisms.
    Wodarz D; Levy DN
    Exp Biol Med (Maywood); 2011 Aug; 236(8):926-37. PubMed ID: 21768164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of heroin-containing substances on the infectivity of the human immunodeficiency virus type 1 in vitro].
    Selimova LM; Khanina TA; Kazennova EV; Zverev SIa; Pokrovskiĭ VV; Bobkov AF
    Vopr Virusol; 2002; 47(5):16-20. PubMed ID: 12522963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.